Prestige Consumer Healthcare (PBH) Amortizatization of Intangibles (2010 - 2015)
Prestige Consumer Healthcare (PBH) recorded quarterly Amortizatization of Intangibles of $750000.0 in Q1 2015, up 15.56% quarter-over-quarter from $649000.0 in Q4 2014, and up 154.24% on a YoY basis from $295000.0 in Q1 2014.
Prestige Consumer Healthcare (PBH) Amortizatization of Intangibles (2010 - 2015) Analysis & Trends
Prestige Consumer Healthcare's Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $750000.0 for Q1 2015.
- In Q1 2015, Amortizatization of Intangibles rose 154.24% year-over-year to $750000.0; the TTM figure through Mar 2015 stood at $2.1 million (down 38.83% YoY), while the FY2015 annual figure was $2.1 million, down 38.83% from the prior year.
- Amortizatization of Intangibles was $750000.0 for Q1 2015 at Prestige Consumer Healthcare, up from $649000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $3.1 million in Q4 2012 to a low of $144000.0 in Q2 2014.
- Historically, Amortizatization of Intangibles has averaged $669411.8 across 5 years, with a median of $404000.0 in 2012.
- The sharpest annual moves came in 2012 and 2014: Amortizatization of Intangibles soared 1244.98% in 2012, then slumped 71.99% in 2014.
- A 5-year view of Amortizatization of Intangibles shows it stood at $229000.0 in 2011, then jumped by 1244.98% to $3.1 million in 2012, then decreased by 24.77% to $2.3 million in 2013, then plunged by 71.99% to $649000.0 in 2014, then rose by 15.56% to $750000.0 in 2015.
- The last three Amortizatization of Intangibles figures came in at $750000.0 (Q1 2015), $649000.0 (Q4 2014), and $543000.0 (Q3 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Prestige Consumer Healthcare | 2.39 Bn | 2.33 Bn | 157.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 750,000.00 |
| Mar 31, 2015 | 750,000.00 |
| Dec 31, 2014 | 649,000.00 |
| Dec 31, 2014 | 649,000.00 |
| Sep 30, 2014 | 543,000.00 |
| Sep 30, 2014 | 543,000.00 |
| Jun 30, 2014 | 144,000.00 |
| Jun 30, 2014 | 144,000.00 |
| Mar 31, 2014 | 295,000.00 |
| Mar 31, 2014 | 295,000.00 |
| Dec 31, 2013 | 2.32 Mn |
| Dec 31, 2013 | 2.32 Mn |
| Sep 30, 2013 | 453,000.00 |
| Sep 30, 2013 | 453,000.00 |
| Jun 30, 2013 | 345,000.00 |
| Jun 30, 2013 | 345,000.00 |
| Mar 31, 2013 | 740,000.00 |
| Mar 31, 2013 | 740,000.00 |
| Dec 31, 2012 | 3.08 Mn |
| Dec 31, 2012 | 3.08 Mn |